Traylor Jeffrey I, Venkatesh Pooja, Fabiano Alexander S, Plitt Aaron R, Patel Ankur, Isaacson Brandon, Mickey Bruce E, Barnett Samuel L
Department of Neurological Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Division of Neurological Surgery, Aurora St. Luke's Hospital, Milwaukee, Wisconsin, United States.
J Neurol Surg B Skull Base. 2024 Jul 24;86(4):395-402. doi: 10.1055/a-2360-9474. eCollection 2025 Aug.
Dizziness is one of the most prevalent and debilitating symptoms associated with vestibular schwannoma (VS), and there are little data on contributing or alleviating factors in the perioperative setting. In this study, we aimed to evaluate whether vestibular nerve sectioning or labyrinthectomy concomitant with surgical resection would improve dizziness in the postoperative period. This is a retrospective study of a consecutive series of VS patients who underwent resection at a large tertiary care center between 2009 and 2023. Dizziness at 6 months was the primary endpoint, whereas facial nerve and hearing outcomes were secondary endpoints. Fisher's exact test was used to identify significant differences between categorical variables, and multivariate logistic regression analysis was performed to identify predictors of dizziness as well as facial nerve and hearing outcomes. A total of 333 patients underwent resection of VS at our institution. There was no significant difference in binary reported dizziness based on surgical approach ( = 0.14). However, patients reported significantly less dizziness at discharge ( 0.01) as well as 6-month ( = 0.02) and 1-year ( 0.01) follow-up in the translabyrinthine group. On the other hand, patients who underwent labyrinth-sparing approaches reported a significant increase in dizziness that remained up to 1 year from the time of surgery. Our data suggest that labyrinthectomy may improve dizziness symptoms in patients with VS. Selective VN sectioning does not appear to affect dizziness or hearing outcomes. Finally, surgical approach does not affect facial nerve outcomes.
头晕是与前庭神经鞘瘤(VS)相关的最常见且使人衰弱的症状之一,而关于围手术期促成因素或缓解因素的数据很少。在本研究中,我们旨在评估前庭神经切断术或与手术切除同时进行的迷路切除术是否会改善术后头晕症状。
这是一项对2009年至2023年期间在一家大型三级医疗中心接受切除术的一系列连续性VS患者的回顾性研究。6个月时的头晕是主要终点,而面神经和听力结果是次要终点。采用Fisher精确检验来确定分类变量之间的显著差异,并进行多因素逻辑回归分析以确定头晕以及面神经和听力结果的预测因素。
共有333例患者在我们机构接受了VS切除术。根据手术方式报告的二元头晕情况无显著差异(P = 0.14)。然而,经迷路入路组的患者在出院时(P < 0.01)以及6个月(P = 0.02)和1年(P < 0.01)随访时报告的头晕明显较少。另一方面,采用保留迷路方法的患者报告头晕显著增加,且从手术时起一直持续到1年。
我们的数据表明,迷路切除术可能会改善VS患者的头晕症状。选择性前庭神经切断术似乎不影响头晕或听力结果。最后,手术方式不影响面神经结果。